Intraperitoneal lymphokine-activated killer cell/interleukin-2 therapy in patients with intra-abdominal cancer: immunologic considerations.

W J Urba; J W Clark; R G Steis; M A Bookman; J W Smith; S Beckner; A E Maluish; J L Rossio; H Rager; J R Ortaldo

doi:10.1093/jnci/81.8.602

Intraperitoneal lymphokine-activated killer cell/interleukin-2 therapy in patients with intra-abdominal cancer: immunologic considerations.

Identifier:nobleid.org/w1/20260515/C39B80CF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C39B80CF.svg?ark=w1%2F20260515%2FC39B80CF)](https://nobleid.org/work/w1/20260515/C39B80CF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Intraperitoneal lymphokine-activated killer cell/interleukin-2 therapy in patients with intra-abdominal cancer: immunologic considerations.

Identifier:nobleid.org/w1/20260515/C39B80CF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C39B80CF.svg?ark=w1%2F20260515%2FC39B80CF)](https://nobleid.org/work/w1/20260515/C39B80CF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work